Vimarsana
Biggest News Aggregation in the World

Page 28 - Exact Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exact Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exact Sciences Today - Breaking & Trending Today

Exact Sciences Co. (NASDAQ:EXAS) Shares Acquired by Artisan Partners Limited Partnership - Vimarsana News

Exact Sciences Co. (NASDAQ:EXAS) Shares Acquired by Artisan Partners Limited Partnership

Artisan Partners Limited Partnership boosted its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 11.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,961,514 shares of the medical research company’s stock after purchasing an additional 418,770 shares […]

Cathie Wood Is Selling This Stock: Should You? - Vimarsana News

Cathie Wood Is Selling This Stock: Should You?

This company hasn't performed well in the past 12 months.

Source: yahoo.com
Cathie Wood Is Selling This Stock: Should You? - Vimarsana News

Cathie Wood Is Selling This Stock: Should You?

The Entire Business World on a Single Page with the Web's Most Comprehensive One-Stop Finance News Hub.

Source: biztoc.com
9 Growth Stocks to Buy Now: Top-2% Fund Manager in 2023 - Vimarsana News

9 Growth Stocks to Buy Now: Top-2% Fund Manager in 2023

A top-2% portfolio manager who engineered a 59% gain in 2023 shared her investing philosophy and strategy, plus nine stocks worth buying now.

Blueshift Asset Management LLC Makes New $402,000 Investment in Exact Sciences Co. (NASDAQ:EXAS) - Vimarsana News

Blueshift Asset Management LLC Makes New $402,000 Investment in Exact Sciences Co. (NASDAQ:EXAS)

Blueshift Asset Management LLC acquired a new stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 5,887 shares of the medical research company’s stock, valued at approximately $402,000. Other […]

Source: wkrb13.com